Key result
Selective serotonin reuptake inhibitors demonstrate beneficial effects on vascular inflammation, endothelial function, arterial stiffening, and potentially delay carotid atherosclerosis.
Why the study?
Antidepressants may possess off-target effects on vascular dysfunction and early atherosclerosis that could mitigate cardiovascular risk in patients with depression.
Do antidepressant medications improve hemodynamic and early atherosclerosis markers in patients with depression?
Do antidepressant medications improve hemodynamic and early atherosclerosis markers in patients with depression?
SSRIs may have direct beneficial off-target effects on vascular integrity and early atherosclerosis markers, independent of their primary antidepressant action.
No takes yet. Share an insight, caveat, or question.
Hypothesis-generating for SSRI vascular protection in animals; clinical translation remains unproven.
Dimoula et al. (2021) conducted a review in Depression. Antidepressants (Selective Serotonin Reuptake Inhibitors) was evaluated on Hemodynamic and early atherosclerosis markers. Selective serotonin reuptake inhibitors demonstrate beneficial effects on vascular inflammation, endothelial function, arterial stiffening, and potentially delay carotid atherosclerosis.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: